COVID-19 Cases Surge Across Asia as JN1 Variant Spreads
The COVID-19 pandemic, which disrupted the world five years ago, is now resurging with a new wave driven by the JN1 variant of Omicron. Countries in Asia, including Singapore, Hong Kong, China, and Thailand, are witnessing a sharp increase in infections.
In Singapore, over 14,000 new cases were reported in early May, marking a 28% rise from the previous week. Hospital admissions have also increased by 30%, although the number of severe (ICU) cases remains relatively low.
Authorities have identified the JN1 variant and its sub-variants, LF7 and NB1.8, as the primary drivers behind the current surge. While there is no definitive evidence that these variants are more severe, they are believed to spread more easily, particularly impacting those with weakened immune systems.
China, Thailand Issue COVID-19 Alerts as Cases Double
China and Thailand have also issued alerts as COVID-19 cases continue to rise. In China, the number of cases among people seeking medical testing has doubled. The Chinese Center for Disease Control and Prevention has warned that the wave may intensify, urging citizens to get booster doses.
In Thailand, two regions have reported a significant uptick in cases, prompting the government to implement stricter preventive measures.
What is the JN1 Variant?
The JN1 variant, a strain of Omicron BA2.86, was first detected in August 2023. In December 2023, the World Health Organization (WHO) classified it as a ‘variant of interest.’
This variant has approximately 30 mutations, making it more capable of evading immunity from previous infections and vaccines. According to Johns Hopkins University, JN1 spreads more easily but is less severe than previous strains.
Are Current Vaccines Effective Against JN1?
The WHO has indicated that the XBB1.5 monovalent booster vaccine is effective against the JN1 variant, increasing antibodies by 19% to 49%. However, existing vaccines may be less effective in neutralizing JN1, highlighting the importance of booster doses.
COVID-19 Situation in India
India has not experienced a major surge in COVID-19 cases during this wave. As of May 19, 2025, the Ministry of Health and Family Welfare reported only 93 cases nationwide.
In Mumbai, doctors have reported some cases with mild symptoms, mainly among younger populations. Indian health experts have urged caution, especially given the rising cases in neighboring countries.
India’s Past COVID-19 Waves: A Recap
-
First Wave (Jan 2020 – Feb 2021):
-
1.08 crore cases reported
-
1.55 lakh deaths
-
Peak: 98,000 cases in a single day (Sept 17, 2020)
-
-
Second Wave (Mar 2021 – May 2021):
-
Delta variant caused the highest death toll
-
1.69 lakh deaths reported
-
Severe oxygen and hospital shortages
-
-
Third Wave (Dec 2021 – Feb 2022):
-
Omicron variant led to a surge in cases
-
Mortality rate dropped to 0.2%
-
10,465 deaths reported
-
As the JN1 variant continues to spread, global health authorities are closely monitoring the situation, emphasizing the importance of vaccinations and booster doses to mitigate the impact of this new wave.
